A Multivariate Study of Non Hodgkin's Lymphoma Involving Proliferation, Apoptosis, bcl-2 and the Microenvironment

References

• Hirt A., Warren E.M., Luethy A.R., Gerdes J., Wagner H.P. Cell cycle analysis in lymphoid neoplasia of childhood: Differences among immunologic subtypes and similarities in the proliferation of normal and leukaemia precursor B cells. Br. J. Hematol. 1992; 80(2)189–193
   PubMed Web of Science ®Google Scholar
• Katz R.L., Wojcik E.M., El-Naggar A.K., Ordonez N.G., Johnston D.A. Proliferation markers in non-hodgkin's lymphoma: A comparative study between cytophotometric quantitation of ki-67 and flow cytometric proliferation index on fine needle aspirates. Anal. Quant. Cytol. Histol. 1993; 15(3)179–186
   PubMed Web of Science ®Google Scholar
• Silvestrini R., Costa A., Veneroni S., DelBino G., Persici P. Comparative analysis of different approaches to investigate cell kinetics. Cell Tissue Kinet. 1988; 21(2)123–131
   PubMedGoogle Scholar
• Braylan R.C., Benson N.A. Cell surface markers and cell cycle analysis of lymphomas. Cytometry 1988; 3: 73–77, Supplement
   Google Scholar
• Costa A., Bonadonna G., Villa E., Valagussa P., Silvestrini R. Labeling index as a prognostic measure in non-hodgkin's lymphoma. J. Natl. Cu. Inst. 1981; 66: 1–9
   PubMed Web of Science ®Google Scholar
• Veneroni S., Costa A., Motta R., Giardini R., Rilke F., Silvestrini R. Comparative [3HJ]—analysis of thymidine labeling index and monoclonal antibody ki-67 in non-hodgkin's lymphomas. Hematolog. Onc. 1988; 6(1)21–28
   PubMed Web of Science ®Google Scholar
• Weiss L.M., Strickler J.G., Medeiros L.J., Gerdes J., Stein H., Warnke R.A. Proliferative rates of non-hodgkin's lymphomas as assessed by ki-67 antibody. Hum. Pathol. 1987; 18: 1155–1159
   PubMed Web of Science ®Google Scholar
• Turner R.R., Layfield L.J., Bishop P.C., Epstein A.L., Parker J.W. Flow cytometric measurement of proliferation—associated nuclear antigen p 105 and DNA content in non-hodgkin's lymphomas. Arch. Pathol. Lab. Med. 1989; 113(8)907–911
   PubMed Web of Science ®Google Scholar
• Brons P.P., Raemaekers J.M., Bogman M.J., van Erp P.E., Boezeman J.B., Pennings A.H., Wessels H.M., Haanen C. Cell cycle kinetics in malignant lymphomas studied with in vivo idodeoxyuridine administration, nuclear ki-67 staining and flow cytometry. Blood 1992; 80(9)2336–2343
   PubMed Web of Science ®Google Scholar
• Hannen C., Bogman M., Brons P.P., Wessels J.M. In vivo measurement of cell kinetics in leukemia and malignant lymphomas after iododeoxyuridine administration and subsequent two parameter flow cytometry. Haematologica 1991; 76(4)35
   Google Scholar
• Yanik G., Yousuf N., Miller M., Swerdlow S., Meyer J., Lampkin B., Raza A. In vivo determination of cell cycle kinetics of non-hodgkin's lymphomas using iododeoxyuridine and bromodeoxyuridine. J. Histochem. Cytochem. 1992; 40(5)723–728
   PubMed Web of Science ®Google Scholar
• Wyllie A.H. The biology of cell death in tumors. Anti-Ca. Res. 1985; 5: 131–136
   PubMed Web of Science ®Google Scholar
• Hollywood K., McCartney J.C. Reduced apoptotic cell death in follicular lymphoma. J. Pathol. 1991; 163: 337–342
   PubMed Web of Science ®Google Scholar
• Leoncini L., Del Vecchio M.T., Megha T., Barbini P., Galieni P., Pileri S., Sabattini E., Gherlinzoni F., Tosi P., Kraft R., Cottier H. Correlations between apoptotic and proliferative indices in malignant non-hodgkin's lymphoma. Am. J. Pathol. 1993; 142(3)755–763
   PubMed Web of Science ®Google Scholar
• Owen-Schaub L.B., Meterissian S., Ford R.J. Fas/APO-1 expression and function on malignant cells of hematologic and non-hematologic origin. J. Immunother 1993; 14(3)234–241
   Web of Science ®Google Scholar
• Wyllie A.H. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview. Ca. Metastasis Rev. 1992; 11(2)95–103
   PubMed Web of Science ®Google Scholar
• Hockenbery D., Nunez G., Milliman C., Schreiber R.D., Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334–336
   PubMed Web of Science ®Google Scholar
• Vaux D.L., Cory S., Adams J.M. Bcl-2 gene promotes hematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440–442
   PubMed Web of Science ®Google Scholar
• Ngan B.-Y., Chen-Levy Z., Weiss L.M., Warnke R.A., Cleary M.L. Expression in non-hodgkin's lymphoma of the bcl-2 protein associated with the t (14;18) chromosomal translocation. N. Eng. J. Med. 1988; 318: 1638
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y., Croce C.M. Analysis of the structure, transcripts and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci., USA 1986; 83(14)5214–5218
   PubMed Web of Science ®Google Scholar
• Reed J.C., Tanaka S. Somatic point mutations in the translocated bcl-2 genes of non-hodgkin's lymphomas and lymphocytic leukemias: Implications for mechanisms of tumor progression. Leuk. Lymphoma 1993; 10(3)157–163
   PubMed Web of Science ®Google Scholar
• Mundle S., Iftikhar A., Khan Z., Shetty V., Payne G., Theodorous S., Gregory S., Raza A. Novel double labeling technique combining bromodeoxyuridine (BrdU) and in situ end labeling (ISEL) to detect birth/death rates in hematological malignancies. Proc. Am. Soc. Hematol., Blood 1993; 82(10), suppl 1: 487aAbstract No. 1934
   Google Scholar
• Raza A., Yousuf N., Umerani A., Mehdi A., Bokhari S.A.J., Sheikh Y., Qadir K., Masterson M., Miller M.A., Lampkin B., Browman G., Bennett J., Goldberg J., Preisler H.D. High expression of TGF-β, long cell cycle times and a unique clustering of S-phase cells in patients with acute promyelocytic leukemia. Blood. 1992; 79(4)1037
   PubMed Web of Science ®Google Scholar
• Chughtai S., Mehdi A., Umerani A., Qadir K., Bokhari S.A.J., Yousuf N., Raza A. Presence of transforming growth factor beta in the hematopoietic microenvironment: Clinical. prognostic and biological implications. CLM Biotechnology 1992; 4(1)11–16
   Google Scholar
• Wijsman J., Jonkar R., Keijzer R., Velde Von De J., Conmelisse C., Von Dierendonck J. A new method to detect apoptosis in paraffin section: In situ end—labeling of fragmented DNA. J. Histochem. Cytochem. 1993; 41(1)7–12
   PubMed Web of Science ®Google Scholar
• Raza A., Mundle S., Iftikhar A., Khan Z., Marcus B., Wright V., Adler S., Gregory S. In situ end labeling (ISEL) demonstrates that as many as ≥ 75% cells in myelodysplastic syndromes are apoptotic. Proc. Am. Soc Hematol, Blood 1993; 82(10), suppl:374a Abstract No. 1482
   Google Scholar
• Chuang L.Y., Hung W.C., Chang C.C., Tsai J.H. Characterization of apoptosis induced by transforming growth factor beta 1 in human hepatoma cells. Anticancer Research 1994; 14(A): 147–152
   Web of Science ®Google Scholar
• Selvakumaran M., Lin H.K., Sjin R.T., Reed J.C., Liebermann D.A., Hoffman B. The novel primary response gene MyDl18 and the proto-oncogenes myc, myc and bcl-2 modulate transforming growth factor betal-1 induced apoptosis of myeloid leukemia cells. Mol. Cell Biol. 1994; 14(4)2352–2360
   PubMed Web of Science ®Google Scholar